SCHEMBL2176378

SCHEMBL2176378

O=C(CC1CC(C(=O)O)CN1)c1cccs1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
MEN1 O00255 2/20 0.45
POLB P06746 2/20 0.45
KMT2A Q03164 2/20 0.45
LMNA P02545 2/20 0.45
HPGD P15428 5/20 0.44
DAO P14920 1/20 0.44
ERCC5 P28715 1/20 0.43
FEN1 P39748 1/20 0.43
GSK3B P49841 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CTNNB1 P35222 1/20 0.39
WNT3A P56704 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5071027 0.79 ALDH1A1 (0.43) ALDH1A1NPC1RAB9AMEN1KMT2A
SCHEMBL2449876 0.76 ALOX15 (0.50) ALDH1A1NPC1RAB9AMEN1POLB
SCHEMBL12262036 0.70 ALDH1A1 (0.60) ALDH1A1NPC1RAB9AMEN1POLB
SCHEMBL5046549 0.67 ALDH1A1 (0.57) ALDH1A1NPC1RAB9AMEN1POLB
SCHEMBL4341460 0.67 ERCC5 (0.72) ALDH1A1NPC1RAB9AMEN1POLB
SCHEMBL759462 0.66 ALDH1A1 (0.84) ALDH1A1NPC1RAB9AMEN1POLB
SCHEMBL6472322 0.65 CYP2D6 (0.54) RAB9AMEN1KMT2ALMNASMN1; SMN2
SCHEMBL711360 0.65 RAB9A (0.75) ALDH1A1NPC1RAB9AMEN1POLB
SCHEMBL2216212 0.65 ALDH1A1 (1.00) ALDH1A1NPC1RAB9AMEN1POLB
Hydrochloric Acid SCHEMBL1373347 0.65 ALDH1A1 (0.81) ALDH1A1NPC1RAB9AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519506-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2012-11-07 EP disclosed
WO-2011082077-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-07-07 WO disclosed